KYMR Kymera Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 5, 2026
$107,39
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$55,26rendah 52m
$130,05tinggi 52m
Kapitalisasi Pasar (MRQ)
$8.89B
P/E (TTM)
-33.0
EPS (TTM)
$-3.25
Pendapatan (TTM)
$105M
lencana Anda
Rentang 52M
$55–$130
Peringkat Analis
BUY
Target Harga
$139
P/E
-33.0
ROE
-24.2%
Margin Laba Bersih
-285.3%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
KYMR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$107.39
Kapitalisasi Pasar (MRQ)
$8.89B
P/E (TTM)
-33.0
EPS (TTM)
$-3.25
Pendapatan (TTM)
$105M
ROE (TTM)
-24.2%
Rentang 52M
$55–$130
KYMR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Tentang Kymera Therapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
sektorHealthcare
industriBiotechnology
karyawan273
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$39M2019-12-31 → 2025-12-31
EPS$-3.692020-12-31 → 2025-12-31
Arus Kas Bebas$-234M2020-12-31 → 2025-12-31
Margin bersih-285.3%2020-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | KYMR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -33.0rata-rata 5T ≈-16.8 | ≈-16.8 | · | · | |
| P/S (TTM) | 84.7rata-rata 5T ≈72.8 | ≈72.8 | 58.4 | Terlalu mahal | |
| P/B (MRQ) | 5.9rata-rata 5T ≈4.3 | ≈4.3 | 7.6 | Kurang nilai | |
| Harga / FCF (TTM) | -37.4rata-rata 5T ≈-18.4 | ≈-18.4 | · | · | |
| Harga / Arus Kas (TTM) | -37.6rata-rata 5T ≈-18.7 | ≈-18.7 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 5.5rata-rata 5T ≈4.3 | ≈4.3 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | KYMR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -333.5%rata-rata 5T ≈-428.0% | ≈-428.0% | -171.2% | Tingkat teratas | |
| Margin EBITDA (TTM) | -325.7%rata-rata 5T ≈-417.8% | ≈-417.8% | -167.1% | Tingkat teratas | |
| Pretax Margin (Margin Sebelum Pajak) | -794.0% | · | -116.7% | Lemah | |
| Margin Laba Bersih (TTM) | -285.3%rata-rata 5T ≈-385.0% | ≈-385.0% | -176.2% | Tingkat teratas | |
| ROA (TTM) | -21.6%rata-rata 5T ≈-24.1% | ≈-24.1% | -22.4% | Lemah | |
| ROE (TTM) | -24.2%rata-rata 5T ≈-27.9% | ≈-27.9% | -20.3% | Lemah | |
| ROIC | -22.1% | · | -22.1% | Sejajar |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | KYMR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 10.3rata-rata 5T ≈6.7 | ≈6.7 | 8.3 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 4.3rata-rata 5T ≈1.8 | ≈1.8 | 3.6 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | KYMR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | -16.7%rata-rata 5T ≈17.9% | ≈17.9% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | -5.7%rata-rata 5T ≈4.3% | ≈4.3% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 2.9% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | KYMR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0rata-rata 5T ≈0.1 | ≈0.1 | 0.1 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$143.6K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.16%
Laporan Berikutnya
Nov 02, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 10, 2026 | $-0.62 | $-0.73 | 14.8% |
| 31 Maret 2026 | $-0.71 | $-0.90 | 21.0% | |
| 31 Des. 2025 | $-0.97 | $-0.81 | -19.4% | |
| 30 Sep. 2025 | $-0.94 | $-0.82 | -14.6% | |
| 30 Juni 2025 | $-0.95 | $-0.83 | -15.0% | |
| 31 Maret 2025 | $-0.82 | $-0.93 | 12.3% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $47M | $79M | $47M | $73M | $34M | $3M | |
| Cost of Revenue | $39M | $47M | $79M | $47M | · | · | · | |
| R&D Expense | $317M | $240M | $189M | $164M | $137M | $62M | $37M | |
| SG&A Expense | $68M | $64M | $55M | $44M | $36M | $18M | $8M | |
| Operating Expenses | $389M | $309M | $244M | $208M | $173M | $80M | $45M | |
| Operating Income | $-349M | $-262M | $-166M | $-161M | $-101M | $-46M | $-42M | |
| Other Non-op | $38M | $38M | $19M | $6M | $313.0K | $711.0K | $959.0K | |
| Pretax Income | $-311M | · | · | · | · | · | · | |
| Income Tax | $0 | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | $-41M | |
| EPS (Basic) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| EPS (Diluted) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| Shares (Basic) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| Shares (Diluted) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| EBITDA | $-341M | $-254M | $-162M | $-158M | $-98M | $-45M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $357M | $120M | $110M | $68M | $48M | $31M | $76M | |
| Receivables | $0 | $0 | $15M | $0 | · | · | · | |
| Prepaid Expense | $23M | $22M | $12M | $10M | $9M | $5M | $888.0K | |
| Current Assets | $871M | $510M | $405M | $419M | $451M | $302M | $93M | |
| PP&E (Net) | $43M | $50M | $48M | $13M | $12M | $11M | $4M | |
| PP&E (Gross) | $65M | $67M | $59M | $20M | $16M | $13M | $5M | |
| Accum. Depreciation | $22M | $16M | $10M | $7M | $4M | $2M | $1M | |
| Other Non-current Assets | $9M | $2M | $2M | $3M | $2M | $30.0K | $2M | |
| Total Assets | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Accounts Payable | $4M | $6M | $7M | $4M | $4M | $4M | $3M | |
| Accrued Liabilities | $42M | $35M | $34M | $28M | $23M | $10M | $5M | |
| Current Liabilities | $83M | $68M | $86M | $71M | $93M | $111M | $35M | |
| Capital Leases | $67M | $72M | $77M | $12M | $13M | $14M | $17M | |
| Other Non-current Liabilities | · | $0 | $0 | $248.0K | $66.0K | $100.0K | · | |
| Total Liabilities | $163M | $142M | $181M | $113M | $146M | $203M | $82M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | · | |
| Retained Earnings | $-1.07B | $-755M | $-531M | $-384M | $-229M | $-129M | $-76M | |
| AOCI | $2M | $-1M | $-552.0K | $-5M | $-660.0K | $-128.0K | $6.0K | |
| Stockholders' Equity | $1.58B | $836M | $395M | $490M | $460M | $284M | $-74M | |
| Liabilities + Equity | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Shares Outstanding | 81,323,532 | 64,890,193 | 55,585,305 | 55,039,380 | 51,536,181 | 44,482,186 | 1,929,516 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $4M | $3M | $2M | $2M | $825.0K | |
| Stock-based Comp | $60M | $55M | $43M | $35M | $25M | $5M | $1M | |
| Other Non-cash | $10M | $-33M | $-3M | $-37M | $-56M | $127M | · | |
| Operating Cash Flow | $-233M | $-195M | $-103M | $-153M | $-129M | $88M | $18M | |
| CapEx | $1M | $13M | $34M | $3M | $2M | $9M | $532.0K | |
| Investing Cash Flow | $-521M | $-404M | $140M | $21M | $-100M | $-423M | $-16M | |
| Financing Cash Flow | $991M | $609M | $4M | $153M | $250M | $289M | $35M | |
| Net Change in Cash | $237M | $10M | $41M | $20M | $21M | $-45M | $36M | |
| Free Cash Flow | $-234M | $-207M | $-137M | $-156M | $-131M | $79M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% | · | |
| Net Margin | -794.0% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% | · | |
| Pretax Margin | -794.0% | · | · | · | · | · | · | |
| EBITDA Margin | -869.9% | -540.2% | -206.1% | -338.0% | -134.7% | -130.9% | · | |
| ROA | -22.9% | -28.8% | -24.9% | -25.6% | -18.3% | -15.1% | · | |
| ROE | -24.4% | -25.9% | -37.2% | -30.9% | -21.3% | -15.8% | · | |
| ROIC | -22.1% | · | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 | 2.7 | · | |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 | 0.3 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | 6.3 | 10.5 | · | · | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $19.42 | $12.88 | · | $8.91 | $8.92 | $6.38 | · | |
| Revenue / Share | $0.46 | $0.63 | $1.35 | $0.87 | · | · | · | |
| Cash Flow / Share | $-2.76 | $-2.59 | $-1.76 | $-2.84 | · | · | · | |
| Cash / Share | $4.39 | $1.85 | · | $1.24 | $0.93 | $0.70 | · | |
| EPS (TTM) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -16.7% | -40.1% | 67.8% | -35.7% | 114.0% | · | · | |
| Revenue CAGR 3Y | -5.7% | -13.5% | 32.2% | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $39M | $47M | $79M | $47M | $73M | $34M | · | |
| Net Income TTM | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | · | |
| Market Cap | $6.33B | $2.61B | · | $1.37B | $3.27B | $2.76B | · | |
| P/E | -21.1 | -13.5 | -10.1 | -8.7 | -30.4 | -19.7 | · | |
| P/S | 161.4 | 55.5 | · | 29.3 | 44.9 | 81.0 | · | |
| P/B | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Cash Flow | -27.2 | -13.4 | · | -9.0 | -25.4 | 31.3 | · | |
| P / FCF | -27.0 | -12.6 | · | -8.8 | -25.1 | 34.9 | · | |
| Earnings Yield | -4.7% | -7.4% | -9.9% | -11.5% | -3.3% | -5.1% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | $48M | $5M | $17M | $9M | $16M | $10M | |
| Cost of Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | · | · | · | · | · | · | |
| R&D Expense | $119M | $98M | $84M | $74M | $78M | $80M | $72M | $60M | $59M | $49M | $53M | $48M | $46M | $42M | $43M | $44M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $18M | $16M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | |
| Operating Expenses | $141M | $119M | $101M | $95M | $96M | $97M | $88M | $76M | $77M | $68M | $67M | $62M | $60M | $55M | $55M | $54M | |
| Operating Income | $-76M | $-84M | $-98M | $-93M | $-85M | $-74M | $-81M | $-72M | $-51M | $-58M | $-19M | $-58M | $-43M | $-45M | $-39M | $-45M | |
| Other Non-op | $14M | $15M | $11M | $10M | $8M | $9M | $10M | $10M | $9M | $9M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $0 | · | $0 | |
| Net Income | $-61M | $-69M | $-87M | $-82M | $-77M | $-66M | $-71M | $-62M | $-42M | $-49M | $-14M | $-53M | $-39M | $-41M | $-35M | $-43M | |
| EPS (Basic) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| EPS (Diluted) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| Shares (Basic) | 98,177,158 | 97,534,269 | · | 87,300,286 | 80,449,405 | 80,146,531 | · | 76,125,975 | 73,059,398 | 70,770,320 | · | 58,421,859 | 58,326,963 | 58,187,038 | · | 54,535,514 | |
| Shares (Diluted) | 98,177,158 | 97,534,269 | · | 87,300,286 | 80,449,405 | 80,146,531 | · | 76,125,975 | 73,059,398 | 70,770,320 | · | 58,421,859 | 58,326,963 | 58,187,038 | · | 54,535,514 | |
| EBITDA | $-76M | $-82M | · | $-93M | $-85M | $-72M | · | $-72M | $-51M | $-56M | · | $-58M | $-43M | $-44M | · | $-45M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124M | $144M | $357M | $113M | $336M | $90M | $120M | $111M | $68M | $94M | $110M | $81M | $52M | $50M | $68M | $156M | |
| Receivables | $20M | · | · | · | $40M | · | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $26M | $27M | $23M | $23M | $23M | $18M | $22M | $17M | $14M | $15M | · | $14M | $14M | $11M | · | $9M | |
| Current Assets | $737M | $677M | $871M | $528M | $728M | $501M | $510M | $569M | $525M | $537M | · | $376M | $385M | $412M | · | $494M | |
| PP&E (Net) | $40M | $42M | $43M | $45M | $49M | $49M | $50M | $51M | $52M | $49M | · | $36M | $27M | $17M | · | $13M | |
| PP&E (Gross) | $66M | $66M | $65M | $67M | $69M | $67M | $67M | $65M | $64M | $60M | · | $46M | $36M | $25M | · | $19M | |
| Accum. Depreciation | $26M | $24M | $22M | $22M | $20M | $18M | $16M | $14M | $12M | $11M | · | $10M | $9M | $8M | · | $6M | |
| Other Non-current Assets | $7M | $8M | $9M | $7M | $5M | $3M | $2M | $0 | $2M | $2M | · | $3M | $3M | $3M | · | $3M | |
| Total Assets | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Accounts Payable | $9M | $13M | $4M | $6M | $6M | $10M | $6M | $6M | $7M | $7M | · | $5M | $4M | $6M | · | $6M | |
| Accrued Liabilities | $48M | $35M | $42M | $29M | $28M | $23M | $35M | $27M | $24M | $16M | · | $26M | $22M | $19M | · | $25M | |
| Current Liabilities | $71M | $63M | $83M | $72M | $88M | $59M | $68M | $67M | $62M | $56M | · | $63M | $55M | $62M | · | $91M | |
| Capital Leases | $64M | $66M | $67M | $68M | $70M | $71M | $72M | $74M | $75M | $76M | · | $77M | $71M | $64M | · | $12M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $8.0K | $230.0K | $237.0K | · | $256.0K | |
| Total Liabilities | $136M | $129M | $163M | $156M | $160M | $132M | $142M | $142M | $141M | $157M | · | $157M | $147M | $152M | · | $126M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $-1.20B | $-1.14B | $-1.07B | $-979M | $-897M | $-820M | $-755M | $-684M | $-621M | $-579M | · | $-516M | $-464M | $-425M | · | $-349M | |
| AOCI | $-7M | $-4M | $2M | $2M | $279.0K | $-58.0K | $-1M | $2M | $-2M | $-2M | · | $-2M | $-4M | $-3M | · | $-6M | |
| Stockholders' Equity | $1.51B | $1.54B | $1.58B | $946M | $971M | $786M | $836M | $893M | $685M | $711M | $395M | $396M | $435M | $462M | $490M | $513M | |
| Liabilities + Equity | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Shares Outstanding | 82,788,253 | 82,182,101 | 81,323,532 | 71,741,174 | 70,557,442 | 65,112,714 | 64,890,193 | 64,748,226 | 61,572,383 | 61,353,146 | · | 55,450,239 | 55,390,259 | 55,276,226 | · | 54,751,429 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $891.0K | $895.0K | $900.0K | $879.0K | $818.0K | $767.0K | |
| Stock-based Comp | $19M | $16M | $14M | $16M | $15M | $14M | $14M | $15M | $14M | $12M | $11M | $12M | $11M | $9M | $9M | $9M | |
| Other Non-cash | · | $-38M | · | · | · | $-30M | · | · | · | $-4M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $-54M | $-89M | $-67M | $-27M | $-60M | $-79M | $-62M | $-50M | $-43M | $-40M | $8M | $-32M | $-35M | $-44M | $-40M | $-34M | |
| CapEx | $473.0K | $434.0K | $106.0K | $181.0K | $695.0K | $467.0K | $936.0K | $-189.0K | $5M | $7M | $12M | $8M | $11M | $4M | $373.0K | $1M | |
| Investing Cash Flow | $20M | $-143M | $-394M | $-235M | $60M | $49M | $69M | $-158M | $16M | $-331M | $19M | $61M | $36M | $25M | $-50M | $-37M | |
| Financing Cash Flow | $14M | $19M | $705M | $40M | $246M | $258.0K | $3M | $251M | $1M | $354M | $2M | $-206.0K | $1M | $1M | $2M | $150M | |
| Net Change in Cash | $-20M | $-213M | $244M | $-223M | $246M | $-30M | $10M | $43M | $-26M | $-16M | $29M | $29M | $2M | $-18M | $-87M | $79M | |
| Free Cash Flow | · | $-89M | · | · | · | $-80M | · | · | · | $-47M | · | · | · | $-48M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -116.3% | -244.9% | · | -3347.4% | -736.8% | -336.8% | · | -1927.9% | -198.5% | -562.2% | · | -1216.4% | -262.7% | -478.8% | · | -469.9% | |
| Net Margin | -94.2% | -201.5% | · | -2973.0% | -667.6% | -296.8% | · | -1670.3% | -164.0% | -472.0% | · | -1118.2% | -235.0% | -432.4% | · | -450.2% | |
| EBITDA Margin | -116.3% | -239.0% | · | -3347.4% | -736.8% | -327.5% | · | -1927.9% | -198.5% | -548.0% | · | -1216.4% | -262.7% | -469.5% | · | -469.9% | |
| ROA | -4.4% | -5.3% | · | -7.7% | -7.8% | -7.3% | · | -7.9% | -6.0% | -6.6% | · | -8.9% | -7.0% | -7.0% | · | -6.7% | |
| ROE | -4.9% | -5.9% | · | -8.9% | -9.2% | -8.8% | · | -9.7% | -7.5% | -8.3% | · | -11.6% | -9.3% | -9.2% | · | -8.6% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 10.8 | · | 7.4 | 8.3 | 8.5 | · | 8.5 | 8.5 | 9.6 | · | 5.9 | 7.1 | 6.6 | · | 5.4 | |
| Quick Ratio | 2.0 | 2.3 | · | 1.6 | 4.3 | 1.5 | · | 1.7 | 1.1 | 1.7 | · | 1.3 | 1.0 | 0.8 | · | 1.7 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.2 | · | · | · | 0.6 | · | · | · | · | · | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $18.23 | $18.73 | · | $13.19 | $13.77 | $12.07 | · | $13.79 | $11.12 | $11.59 | · | $7.13 | $7.86 | $8.36 | · | $9.37 | |
| Revenue / Share | $0.66 | $0.35 | · | $0.03 | $0.14 | $0.28 | · | $0.05 | $0.35 | $0.15 | · | $0.08 | $0.28 | $0.16 | · | $0.18 | |
| Cash Flow / Share | · | $-0.91 | · | · | · | $-0.99 | · | · | · | $-0.56 | · | · | · | $-0.76 | · | · | |
| Cash / Share | $1.50 | $1.75 | · | $1.57 | $4.76 | $1.38 | · | $1.71 | $1.10 | $1.52 | · | $1.46 | $0.95 | $0.91 | · | $2.84 | |
| EPS (TTM) | $-3.25 | $-3.58 | · | $-3.60 | $-3.48 | $-3.11 | · | $-2.34 | $-2.42 | $-2.51 | · | $-2.86 | $-2.75 | $-2.86 | · | $-2.95 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $105M | $51M | · | $44M | $45M | $59M | · | $88M | $89M | $79M | · | $47M | $52M | $47M | · | $46M | |
| Net Income TTM | $-300M | $-315M | · | $-295M | $-275M | $-241M | · | $-167M | $-158M | $-155M | · | $-167M | $-158M | $-159M | · | $-154M | |
| Market Cap | $9.49B | $6.84B | · | $4.06B | $3.08B | $1.78B | · | $3.06B | $1.84B | $2.47B | · | $771M | $1.27B | $1.64B | · | $1.19B | |
| P/E | -35.3 | -23.3 | · | -15.7 | -12.5 | -8.8 | · | -20.2 | -12.3 | -16.0 | · | -4.9 | -8.4 | -10.4 | · | -7.4 | |
| P/S | 90.4 | 133.0 | · | 92.8 | 68.9 | 30.3 | · | 35.0 | 20.8 | 31.1 | · | 16.5 | 24.6 | 35.1 | · | 25.9 | |
| P/B | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Tangible Book | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Cash Flow | · | -77.0 | · | · | · | -22.5 | · | · | · | -62.3 | · | · | · | -37.3 | · | · | |
| Earnings Yield | -2.8% | -4.3% | · | -6.4% | -8.0% | -11.4% | · | -4.9% | -8.1% | -6.2% | · | -20.6% | -12.0% | -9.7% | · | -13.6% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $39M | $47M | $79M | $47M | $73M |
| Margin Operasi % | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% |
| Laba Bersih | $-311M | $-224M | $-147M | $-155M | $-100M |
| EPS Dilusian | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 |
| Rasio Cepat | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-234M | $-207M | $-137M | $-156M | $-131M |
Pemilik institusional (13F) 305 pengaju · $10.2B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
305
Nilai yang dipegang
$10.2B
Posisi baru
53
Posisi yang keluar
23
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 53 (+7 vs Kuartal sebelumnya) | 23 (-13 vs Kuartal sebelumnya) | 101 (+5 vs Kuartal sebelumnya) | 80 (+8 vs Kuartal sebelumnya) | +431K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $1.416.089.213 | 12.349.256 | 13,95% | Saham |
| BAKER BROS. ADVISORS LP | $992.725.940 | 8.657.242 | 9,78% | Saham |
| Avoro Capital Advisors LLC | $857.129.238 | 7.474.747 | 8,44% | Saham |
| BlackRock, Inc. | $635.066.535 | 5.538.210 | 6,25% | Saham |
| VANGUARD GROUP INC | $487.685.380 | 6.267.644 | 4,80% | Saham |
| BVF INC/IL | $444.008.203 | 3.872.052 | 4,37% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $421.415.461 | 3.675.028 | 4,15% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $343.114.771 | 2.992.193 | 3,38% | Saham |
| Siren, L.L.C. | $336.651.626 | 2.935.830 | 3,32% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $336.255.785 | 2.932.378 | 3,31% | Saham |
| Atlas Venture Life Science Advisors, LLC | $326.527.526 | 2.847.541 | 3,22% | Saham |
| STATE STREET CORP | $313.877.705 | 2.737.226 | 3,09% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $208.316.264 | 1.816.331 | 2,05% | Saham |
| Capital Research Global Investors | $159.262.984 | 1.388.881 | 1,57% | Saham |
| GOLDMAN SACHS GROUP INC | $136.151.475 | 1.187.333 | 1,34% | Saham |
| UBS Group AG | $115.561.789 | 1.007.777 | 1,14% | Saham |
| Driehaus Capital Management LLC | $105.408.448 | 919.233 | 1,04% | Saham |
| Merck & Co., Inc. | $88.544.161 | 772.165 | 0,87% | Saham |
| NORGES BANK | $86.833.399 | 757.246 | 0,86% | Saham |
| FEDERATED HERMES, INC. | $85.933.469 | 749.398 | 0,85% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $85.421.500 | 745.152 | 0,84% | Saham |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84.955.104 | 740.866 | 0,84% | Saham |
| ALLIANCEBERNSTEIN L.P. | $81.750.884 | 981.521 | 0,81% | Saham |
| Holocene Advisors, LP | $72.996.514 | 636.579 | 0,72% | Saham |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $72.951.379 | 875.872 | 0,72% | Saham |
| NORTHERN TRUST CORP | $66.727.276 | 581.907 | 0,66% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.744.024 | 529.729 | 0,60% | Saham |
| FRANKLIN RESOURCES INC | $59.060.783 | 515.050 | 0,58% | Saham |
| EVENTIDE ASSET MANAGEMENT, LLC | $57.811.287 | 504.210 | 0,57% | Saham |
| JENNISON ASSOCIATES LLC | $57.676.487 | 502.978 | 0,57% | Saham |
| Woodline Partners LP | $57.434.534 | 500.868 | 0,57% | Saham |
| Rock Springs Capital Management LP | $51.963.399 | 453.156 | 0,51% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $51.570.654 | 449.731 | 0,51% | Saham |
| Boxer Capital Management, LLC | $49.204.897 | 429.100 | 0,48% | Saham |
| Pictet Asset Management Holding SA | $44.984.008 | 395.540 | 0,44% | Saham |
| BANK OF AMERICA CORP /DE/ | $43.378.055 | 378.286 | 0,43% | Saham |
| BRAIDWELL LP | $43.363.951 | 378.163 | 0,43% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $43.100.784 | 375.868 | 0,42% | Saham |
| TWO SIGMA INVESTMENTS, LP | $42.585.457 | 371.374 | 0,42% | Saham |
| Clearbridge Investments, LLC | $39.815.871 | 347.221 | 0,39% | Saham |
| Octagon Capital Advisors LP | $35.547.700 | 310.000 | 0,35% | Saham |
| Nextech Invest Ltd. | $31.981.004 | 278.896 | 0,31% | Saham |
| Alyeska Investment Group, L.P. | $31.701.095 | 276.455 | 0,31% | Saham |
| TD Asset Management Inc | $31.293.443 | 272.900 | 0,31% | Saham |
| VOYA INVESTMENT MANAGEMENT LLC | $30.951.039 | 269.914 | 0,30% | Saham |
| TWO SIGMA ADVISERS, LP | $29.085.378 | 373.800 | 0,29% | Saham |
| Commodore Capital LP | $28.667.500 | 250.000 | 0,28% | Saham |
| RTW INVESTMENTS, LP | $27.520.800 | 240.000 | 0,27% | Saham |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $26.799.869 | 233.713 | 0,26% | Saham |
| GILDER GAGNON HOWE & CO LLC | $26.265.508 | 229.053 | 0,26% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Hrustanovic Gorjan ×2 pengajuan | 26 Juni 2026 | 6,30% | Amandemen | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×4 pengajuan | 11 Des. 2025 | 10,90% | Amandemen | Struktur modal | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×5 pengajuan | 9 Jan. 2024 | · | Pengajuan awal | · | SEC |
| Vertex Pharmaceuticals Incorporated ×2 pengajuan | 5 Juni 2023 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 25 orang dalam · 10 pejabat · 13 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Nello Mainolfi | Chief Executive Officer | 1 Okt. 2026 M | 666.568 | 0 | 26 | $-36.819.541 |
| Bruce N. Jacobs | Chief Financial Officer | 30 Juni 2026 M | 244.883 | 0 | 15 | $-9.956.105 |
| Jeremy G Chadwick | Chief Operating Officer | 27 Mei 2026 S | 44.018 | 0 | 29 | $-15.599.618 |
| Brian Adams | Chief Legal Officer | 4 Sep. 2026 S | 50.254 | 0 | 3 | $-744.297 |
| Terence Rooney | Chief Medical Officer | 27 Juli 2026 A | 38.000 | 0 | 0 | $0 |
| Noah Goodman | Chief Business Officer | 1 Juli 2026 S | 47.179 | 0 | 9 | $-2.223.845 |
| Jared Gollob | Chief Medical Officer | 2 Maret 2026 A | 117.134 | 0 | 18 | $-9.134.491 |
| Ellen Chiniara | Chief Legal Officer | 3 Maret 2025 A | 80.085 | 0 | 0 | $0 |
| Elaine Caughey | Chief Business Officer | 1 Maret 2023 A | 18.986 | 0 | 0 | $0 |
| Richard Chesworth | Chief Scientific Officer | 27 Agu 2021 M | 0 | 0 | 0 | $0 |
| Bruce Booth | Direktur | 29 Juni 2026 S | 462.856 | 0 | 160 | $-226.031.370 |
| Hrustanovic Gorjan | Direktur | 24 Juni 2026 A | · | 0 | 0 | $0 |
| Elena Ridloff | Direktur | 24 Juni 2026 A | 0 | 0 | 4 | $-1.285.644 |
| Pamela Esposito | Direktur | 24 Juni 2026 A | 1.000 | 0 | 12 | $-3.054.174 |
| Jeffrey W. Albers | Direktur | 24 Juni 2026 A | 0 | 0 | 3 | $-744.757 |
| Victor Sandor | Direktur | 24 Juni 2026 A | · | 0 | 0 | $0 |
| John Maraganore | Direktur | 24 Juni 2026 A | · | 0 | 0 | $0 |
| Leigh Morgan | Direktur | 18 Juni 2024 A | · | 0 | 0 | $0 |
| Joanna Horobin | Direktur | 7 Juni 2024 M | 0 | 0 | 0 | $0 |
| Donald William Nicholson | Direktur | 15 Juni 2022 A | · | 0 | 0 | $0 |
| Steven Edward Hall | Direktur | 25 Agu 2020 C | 2.192.249 | 0 | 0 | $0 |
| Andrew Hedin | Direktur | 20 Agu 2020 A | · | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | Pemilik 10% | 18 Mei 2021 J | 5.763.012 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Pemilik 10% | 25 Agu 2020 C | 959.211 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | Pemilik 10% | 25 Agu 2020 C | 467.932 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 49 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| HAPS · Harbor ETF Trust | 2,21% | 36.388 NS | 31 Juli 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,75% | 45.819 SH | 2 Okt. 2026 | Harian |
| GURU · Global X Funds | 1,41% | 8.375 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,90% | 43.133 NS | 31 Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,80% | 3.605 NS | 31 Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,62% | 543.907 SH | 11 Sep. 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,61% | 5.875 SH | 2 Okt. 2026 | Harian |
| ESSC · Strategy Shares | 0,44% | 1.522 NS | 31 Juli 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,43% | 24.014 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,40% | 487.324 SH | 11 Sep. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,35% | 55.351 SH | 19 Agu 2026 | Harian |
| PWS · Pacer Funds Trust | 0,25% | 589 NS | 31 Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,25% | 2.092 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,24% | 1.600.729 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,22% | 360.394 SH | 19 Agu 2026 | Harian |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 14.574 NS | 31 Juli 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,21% | 871.540 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,21% | 29.987 NS | 31 Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 32.324 SH | 19 Agu 2026 | Harian |
| FFSM · FIDELITY COVINGTON TRUST | 0,18% | 25.352 NS | 31 Juli 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 17.965 NS | 31 Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,13% | 7.208 NS | 31 Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,10% | 152.728 NS | 31 Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,10% | 8.361 SH | 11 Sep. 2026 | Harian |
| ESML · iShares Trust | 0,09% | 22.280 SH | 11 Sep. 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1.509.269 SH | 19 Agu 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 19.721 SH | 2 Okt. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 726.357 SH | 19 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 9.461 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,08% | 134.854 SH | 19 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 21.341 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,06% | 3.284 SH | 11 Sep. 2026 | Harian |
| FBCG · FIDELITY COVINGTON TRUST | 0,05% | 31.560 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 113.415 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 5.280 NS | 31 Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.058 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 15.117 NS | 31 Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 2.447 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 2.089.726 SH | 19 Agu 2026 | Harian |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 49.584 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.163 SH | 19 Agu 2026 | Harian |
| ITOT · iShares Trust | 0,01% | 81.928 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,01% | 17.103 SH | 11 Sep. 2026 | Harian |
| ESGV · VANGUARD WORLD FUND | 0,01% | 13.837 SH | 19 Agu 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 9.292 NS | 31 Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 151 NS | 31 Juli 2026 | N-PORT |
| IWN · iShares Trust | · | 102.204 SH | 11 Sep. 2026 | Harian |
| ISCB · iShares Trust | · | 2.398 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 6.014 SH | 11 Sep. 2026 | Harian |
KYMR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 30 analis
BELI
Target median
$135.50
+26,2%
10 33,3%
Beli Kuat
16 53,3%
Beli
4 13,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
22 analis · 2026-10-04Target rata-rata $138.64 +29,1%
← Di bawah semua target
Harga saat ini $107.39
Rendah$111.00
Rata-rata$138.64
Tinggi$180.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | · |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | · |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | · |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | · |
| PCVX | $6.05B | -8.2 | · | · | -26.6% | · |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | · |
| PRAX | $7.43B | -21.9 | 249.5% | · | -47.3% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 5, 2026